Vortioxetine (Brintellix): a "Multi-Modal Antidepressant"
The new selective serotonin reuptake inhibitor (SSRI) antidepressant vortioxetine (Brintellix) offers no proven superiority in efficacy or tolerability over older, less expensive, and better tested agents.
Topiramate and Long-term Weight Loss in Schizophrenia Patients
For obese patients with schizophrenia, the anticonvulsant topiramate (Topamax) appears to promote weight loss during treatment and for long after it is discontinued.
Paliperidone Palmitate (Invega Sustenna) Approved by FDA for Schizoaffective Disorder; Chronic Marijuana Use Causes Structural Changes in the Brain
Risks of Antipsychotic Drugs in Older Patients
Antipsychotic treatment in elderly patients is associated with an increased risk of mortality and may contribute to acute kidney injury.
the source for
up-to-date information on psychotropic medications and other biological treatments for mental disorders
Register now, or if you are completing your residency and received a promotional mailing, enter your code.
Subscribing to BTP is easy! You can receive the print version with online access, or online only.
Dr. Gelenberg invites you to join him in Tucson, AZ the week of February 16, 2015 for the 2015 Update on Psychiatry conference. This 4-day live multi-accredited conference will be held at the JW Marriott Starr Pass. This year's program features outstanding speakers from our University and academic institutions around the country including Dr. Alan Gelenberg. Current clinical practices and research focusing on a variety of psychopharmacology topics will be addressed.
For more information and to register go to www.psychopharm.arizona.edu.
Question please contact Leticia Lovallo at firstname.lastname@example.org or 520.626.1392
- J. Rutherford, M.D.